CREG1 通过抑制心肌细胞的铁死亡来减轻阿霉素诱导的心脏毒性。
CREG1 attenuates doxorubicin-induced cardiotoxicity by inhibiting the ferroptosis of cardiomyocytes.
发表日期:2024 Jul 29
作者:
Dan Liu, Xiaoli Cheng, Hanlin Wu, Haixu Song, Yuxin Bu, Jing Wang, Xiaolin Zhang, Chenghui Yan, Yaling Han
来源:
Redox Biology
摘要:
阿霉素 (DOX) 引起的心脏毒性限制了 DOX 在癌症患者中的应用。目前,DOX引起的心脏毒性尚无有效的预防或治疗方法。 E1A刺激基因的细胞阻遏物(CREG1)是一种心脏保护因子,在维持心肌细胞分化和稳态中发挥重要作用。然而CREG1在DOX诱导的心脏毒性中的作用和机制尚未阐明。在体内,采用C57BL/6J小鼠、CREG1转基因小鼠和心脏特异性CREG1敲除小鼠建立DOX诱导的心脏毒性模型。 H
Doxorubicin (DOX)-induced cardiotoxicity limits the application of DOX in cancer patients. Currently, there is no effective prevention or treatment for DOX-induced cardiotoxicity. The cellular repressor of E1A-stimulated genes (CREG1) is a cardioprotective factor that plays an important role in the maintenance of cardiomyocytes differentiation and homeostasis. However, the role and mechanism of CREG1 in DOX-induced cardiotoxicity has not yet been elucidated.In vivo, C57BL/6J mice, CREG1 transgenic and cardiac-specific CREG1 knockout mice were used to establish a DOX-induced cardiotoxicity model. H&E staining, Masson's trichrome, WGA staining, real-time PCR, and western blotting were performed to examine fibrosis and ferroptosis in the myocardium. In vitro, neonatal mouse cardiomyocytes (NMCMs) were cultured and stimulated with DOX, CREG1-overexpressed adenovirus, and small interfering RNA was used to establish CREG1 overexpression or knockdown cardiomyocytes. Transcriptomics, real-time PCR, western blotting, and immunoprecipitation were used to examine the roles and mechanisms of CREG1 in cardiomyocytes ferroptosis.The mRNA and protein levels of CREG1 were reduced in the hearts and NMCMs after DOX treatment. CREG1 overexpression alleviated myocardial damage and inhibited DOX-induced ferroptosis in the myocardium. CREG1 deficiency in the heart aggravated DOX-induced cardiotoxicity and ferroptosis. In vitro, CREG1 overexpression inhibited cardiomyocytes ferroptosis induced by DOX, and CREG1 knockdown aggravated DOX-induced cardiotoxicity. Mechanistically, CREG1 inhibited the mRNA and protein expression of pyruvate dehydrogenase kinase 4 (PDK4) by regulating the F-box and WD repeat domain containing 7 (FBXW7)-forkhead box O1 (FOXO1) pathway. PDK4 deficiency reversed the effects of CREG1 knockdown on cardiomyocytes ferroptosis following DOX treatment.CREG1 alleviated DOX-induced cardiotoxicity by inhibiting ferroptosis in cardiomyocytes. Our findings may help clarify the new roles of CREG1 in the development of DOX-induced cardiotoxicity.Copyright © 2024 The Authors. Published by Elsevier B.V. All rights reserved.